Drug development and formulation


HBM contact: Dr Alexander Asam

Company status: private

APR is a pharma company developing and out-licensing new drugs and new drug formulations for a variety of applications based on the company’s science driven formulation technology and expertise. These technologies include orally dispersible and disintegrating films. Application areas include Rx products as well as OTC products. 

© HBM Partners AG  |  Bundesplatz 1  |  6300 Zug, Switzerland  |  Phone  +41 43 888 7171